Genetic susceptibility to type 1 diabetes in childhood – estimation of HLA class II associated disease risk and class II effect in various phases of islet autoimmunity

Pediatric Diabetes

Volumn 17, Issue , 2016, Pages 8-16

  Ilonen, J ^a   Kiviniemi, M ^a   Lempainen, J ^a   Simell, O ^a,b   Toppari, J ^a,b   Veijola, R ^c,d   Knip, M ^e,f,g  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^f FOLKHÄLSAN RESEARCH CENTER   (Finland)

^g TAMPERE UNIVERSITY HOSPITAL   (Finland)

Author keywords

genetics; HLA class II; islet autoimmunity; type 1 diabetes

Indexed keywords

AUTOANTIBODY; HLA ANTIGEN CLASS 2; HLA DQ2 ANTIGEN; HLA DQ8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN;

ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; DISEASE COURSE; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA ANTIGEN CLASS 2 GENE; HLA DQ2 GENE; HLA DQ8 GENE; HLA DR3 GENE; HLA DR4 GENE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; PANCREAS ISLET CELL; PRIORITY JOURNAL; SEROCONVERSION;

EID: 84978410573     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/pedi.12327     Document Type: Article

References (31)

1. Thomsen M, Platz P, Andersen OO et al. MLC typing in juvenile diabetes mellitus and idiopathic Addison's disease. Transplant Rev 1975: 22: 125–147.
2. Ilonen J, Herva E, Tiilikainen A, Akerblom HK, Koivukangas T, Kouvalainen K. HLA-Dw2 as a marker of resistance against juvenile diabetes mellitus. Tissue Antigens 1978: 11: 144–146.
3. Park Y, Eisenbarth GS. Genetic susceptibility factors of type 1 diabetes in Asians. Diabetes Metab Res Rev 2001: 17: 2–11.
4. Ilonen J, Kocova M, Lipponen K, Sukarova-Angelovska E, Jovanovska A, Knip M. HLA-DR-DQ haplotypes and type 1 diabetes in Macedonia. Hum Immunol 2009: 70: 461–463.
5. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987: 329: 599–604.
6. Khalil I, d'Auriol L, Gobet M et al. A combination of HLA-DQ beta Asp57-negative and HLA DQ alpha Arg52 confers susceptibility to insulin-dependent diabetes mellitus. J Clin Invest 1990: 85: 1315–1319.
7. Undlien DE, Friede T, Rammensee HG et al. HLA-encoded genetic predisposition in IDDM: DR4 subtypes may be associated with different degrees of protection. Diabetes 1997: 46: 143–149.
8. Varney MD, Valdes AM, Carlson JA et al. HLA DPA1, DPB1 alleles and haplotypes contribute to the risk associated with type 1 diabetes: analysis of the type 1 diabetes genetics consortium families. Diabetes 2010: 59: 2055–2062.
9. Nejentsev S, Howson JM, Walker NM et al. Localization of type 1 diabetes susceptibility to the MHC class I genes HLA-B and HLA-A. Nature 2007: 450: 887–892.
10. Noble JA, Valdes AM, Varney MD et al. HLA class I and genetic susceptibility to type 1 diabetes: results from the Type 1 Diabetes Genetics Consortium. Diabetes 2010: 59: 2972–2979.
11. Mikk ML, Kiviniemi M, Laine AP et al. The HLA-B*39 allele increases type 1 diabetes risk conferred by HLA-DRB1*04:04-DQB1*03:02 and HLA-DRB1*08-DQB1*04 class II haplotypes. Hum Immunol 2014: 75: 65–70.
12. Trowsdale J, Knight JC. Major histocompatibility complex genomics and human disease. Annu Rev Genomics Hum Genet 2013: 14: 301–323.
13. Onengut-Gumuscu S, Chen WM, Burren O et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat Genet 2015: 47: 381–386.
14. Hekkala A, Ilonen J, Knip M, Veijola R. Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis. Eur J Endocrinol 2011: 165: 813–817.
15. Ilonen J, Hammais A, Laine AP et al. Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 2013: 62: 3636–3640.
16. Lempainen J, Laine AP, Hammais A et al. Non-HLA gene effects on the disease process of type 1 diabetes: from HLA susceptibility to overt disease. J Autoimmun 2015: 61: 45–53.
17. Kiviniemi M, Hermann R, Nurmi J et al. A high-throughput population screening system for the estimation of genetic risk for type 1 diabetes: an application for the TEDDY (the Environmental Determinants of Diabetes in the Young) study. Diabetes Technol Ther 2007: 9: 460–472.
18. Thomson G, Valdes AM, Noble JA et al. Relative predispositional effects of HLA class II DRB1-DQB1 haplotypes and genotypes on type 1 diabetes: a meta-analysis. Tissue Antigens 2007: 70: 110–127.
19. Lambert AP, Gillespie KM, Thomson G et al. Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom. J Clin Endocrinol Metab 2004: 89: 4037–4043.
20. Thomson G. HLA disease associations: models for the study of complex human genetic disorders. Crit Rev Clin Lab Sci 1995: 32: 183–219.
21. Noble JA, Valdes AM. Genetics of the HLA region in the prediction of type 1 diabetes. Curr Diab Rep 2011: 11: 533–542.
22. Hermann R, Turpeinen H, Laine AP et al. HLA DR-DQ-encoded genetic determinants of childhood-onset type 1 diabetes in Finland: an analysis of 622 nuclear families. Tissue Antigens 2003: 62: 162–169.
23. Hu X, Deutsch AJ, Lenz TL et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat Genet 2015: 47: 898–905.
24. Nejentsev S, Reijonen H, Adojaan B et al. The effect of HLA-B allele on the IDDM risk defined by DRB1*04 subtypes and DQB1*0302. Diabetes 1997: 46: 1888–1892.
25. Valdes AM, Erlich HA, Noble JA. Human leukocyte antigen class I B and C loci contribute to type 1 diabetes (T1D) susceptibility and age at T1D onset. Hum Immunol 2005: 66: 301–313.
26. Zavattari P, Lampis R, Motzo C et al. Conditional linkage disequilibrium analysis of a complex disease superlocus, IDDM1 in the HLA region, reveals the presence of independent modifying gene effects influencing the type 1 diabetes risk encoded by the major HLA-DQB1, −DRB1 disease loci. Hum Mol Genet 2001: 10: 881–889.
27. Bilbao JR, Calvo B, Aransay AM et al. Conserved extended haplotypes discriminate HLA-DR3-homozygous Basque patients with type 1 diabetes mellitus and celiac disease. Genes Immun 2006: 7: 550–554.
28. Skyler JS. Prevention and reversal of type 1 diabetes – past challenges and future opportunities. Diabetes Care 2015: 38: 997–1007.
29. Lipponen K, Gombos Z, Kiviniemi M et al. Effect of HLA class I and class II alleles on progression from autoantibody positivity to overt type 1 diabetes in children with risk-associated class II genotypes. Diabetes 2010: 59: 3253–3256.
30. Mbunwe E, Van der Auwera BJ, Weets I et al. In antibody-positive first-degree relatives of patients with type 1 diabetes, HLA-A*24 and HLA-B*18, but not HLA-B*39, are predictors of impending diabetes with distinct HLA-DQ interactions. Diabetologia 2013: 56: 1964–1970.
31. Harjutsalo V, Sund R, Knip M, Groop P-H. Incidence of type 1 diabets in Finland. JAMA 2013: 310: 427–428.